OrbiMed’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

OrbiMed’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-111,120	Closed	-$1.8M	–	148
2022 Q1	$1.8M	Hold	111,120	–	–	0.03%	132
2021 Q4	$5.27M	Hold	111,120	–	–	0.07%	134
2021 Q3	$8.05M	Hold	111,120	–	–	0.09%	139
2021 Q2	$9.33M	Buy	111,120 +92,555	+499%	+$6.11M	0.09%	129
2021 Q1	$900K	Sell	18,565 -587,505	-97%	-$31.9M	0.01%	155
2020 Q4	$28.6M	Hold	606,070	–	–	0.25%	85
2020 Q3	$28.5M	Buy	+606,070	New	+$20M	0.36%	71

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OrbiMed's NBP Position: Q2 2022 in Review

OrbiMed sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 111,120 shares — an estimated $1.8M sold.

OrbiMed first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $28.6M in Q4 2020. 96 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

OrbiMed reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
OrbiMed sold 111,120 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1.8M.
OrbiMed first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
OrbiMed's NovaBridge Biosciences American Depositary Shares position peaked at $28.6M in Q4 2020.
96 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on OrbiMed's 13F filing for Q2 2022, filed 15 Aug 2022.